What we achieved in 2025, together
Date
Research news
Date
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Date
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Date
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Date
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
Date
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
Date
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Date
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Date
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
Date
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
Date
New research shows that scrapping prescription charges for Parkinson's and inflammatory bowel disease could save the NHS money.